https://www.fda.gov/media/158165/download
Medical History
? Positive SARS-CoV-2 test (Confirmation of a positive home rapid SARS-CoV-2 test result with additional direct SARS-CoV-2 viral testing is not required.) ? Age ≥ 18 years OR > 12 years of age and weighing at least 40 kg
? Has one or more risk factors for progression to severe COVID-191 (Healthcare providers should consider the benefit-risk for an individual patient.)
? Symptoms consistent with mild to moderate COVID-192
? Symptom onset within 5 days (Prescriber is encouraged to include a note to the pharmacist in the prescription stating: Please fill prescription by [insert date]. This prescription fill by date is within 5 days from symptom onset and complies with the patient eligibility criteria under the EUA.)
? Not requiring hospitalization due to severe or critical COVID-19 at treatment initiation
? No known or suspected severe renal impairment (eGFR < 30 mL/min) ? Note that a dose reduction is required for patients with moderate renal
blabla好多自己看。